# Organogenesis (ORGO) — Earnings

ORGO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/orgo/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.71 |
| EPS estimate | −$0.35 |
| EPS surprise | −103.91% |
| Revenue surprise | −19.38% |
| Revenue | $43.8M |
| Revenue estimate | $54.3M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1661181/000119312526338049/orgo-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/a8e2b99d-2603-4654-4e62-98085a155777.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.35 | −$0.71 | -103.91% | $54.3M | $43.8M |
| Q1 2026 | May 7, 2026 | −$0.29 | −$0.37 | -26.34% | $43.3M | $36.3M |
| Q4 2025 | Feb 26, 2026 | $0.21 | $0.31 | 47.43% | $172.0M | $225.1M |
| Q3 2025 | Nov 6, 2025 | $0.07 | $0.12 | 88.77% | $134.1M | $150.9M |
| Q2 2025 | Aug 7, 2025 | −$0.05 | −$0.06 | -26.00% | $103.4M | $101.0M |
| Q1 2025 | May 8, 2025 | −$0.04 | −$0.17 | -353.33% | $90.8M | $86.7M |
| Q4 2024 | Feb 27, 2025 | −$0.01 | $0.04 | 450.88% | $109.6M | $126.7M |
| Q3 2024 | Nov 12, 2024 | −$0.02 | $0.09 | 550.00% | $108.8M | $115.2M |
| Q2 2024 | Aug 8, 2024 | $0.01 | −$0.13 | -2700.00% | $121.3M | $130.2M |
| Q1 2024 | May 9, 2024 | −$0.02 | −$0.02 | 35.62% | $101.1M | $110.0M |
| Q4 2023 | Feb 29, 2024 | $0.01 | $0.02 | 125.00% | $109.1M | $99.7M |
| Q3 2023 | Nov 9, 2023 | $0.01 | $0.04 | 221.43% | $111.4M | $108.5M |
| Q2 2023 | Aug 9, 2023 | $0.03 | $0.05 | 49.19% | $115.1M | $117.3M |
| Q1 2023 | May 10, 2023 | −$0.02 | −$0.00 | 87.37% | $95.5M | $107.6M |
| Q4 2022 | Mar 1, 2023 | $0.05 | $0.07 | 42.00% | $122.4M | $115.5M |
| Q3 2022 | Nov 9, 2022 | $0.06 | $0.04 | -37.88% | $120.9M | $116.9M |
| Q2 2022 | Aug 9, 2022 | $0.08 | $0.09 | 5.07% | $120.9M | $121.4M |
| Q1 2022 | May 10, 2022 | $0.05 | $0.01 | -82.80% | $95.9M | $98.1M |
| Q4 2021 | Mar 1, 2022 | $0.08 | $0.40 | 388.89% | $124.7M | $128.6M |
| Q3 2021 | Nov 9, 2021 | $0.06 | $0.09 | 44.00% | $112.2M | $113.8M |

## Frequently Asked Questions

### When did Organogenesis (ORGO) last report earnings?

Organogenesis last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did ORGO beat earnings estimates?

No. Organogenesis reported EPS of −$0.71 for Q2 2026 against a −$0.35 estimate — a 103.91% miss.

### How much revenue did ORGO report last quarter?

Organogenesis reported $43.8M in revenue for Q2 2026, against a consensus estimate of $54.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).